CXCR2 antibodies target tumors and neutrophils, enhancing immunotherapy in ARID1A-deficient pancreatic cancer
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
Pancreatic cancer has long been regarded as one of the most difficult cancers to treat, not only because malignant cells ...
In a groundbreaking study poised to reshape our understanding of cancer progression, researchers at Ludwig Lausanne have unveiled a pivotal ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine